GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Titan Medical Inc (OTCPK:TMDIF) » Definitions » Institutional Ownership

TMDIF (Titan Medical) Institutional Ownership : 0.00% (As of Apr. 02, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Titan Medical Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Titan Medical's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Titan Medical's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Titan Medical's Float Percentage Of Total Shares Outstanding is 99.98%.


Titan Medical Institutional Ownership Historical Data

The historical data trend for Titan Medical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Medical Institutional Ownership Chart

Titan Medical Historical Data

The historical data trend for Titan Medical can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.03 0.14

Titan Medical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Titan Medical Business Description

Traded in Other Exchanges
N/A
Address
76 Berkeley Street, Toronto, ON, CAN, M5A 2W7
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.

Titan Medical Headlines